U.S. federal trademark · Serial No. 86563378 · Reg. No. 4928946
Medical services, namely, providing personalized drug therapy management programs to cancer patients based on the patient's genetic testing results; genetic testing for medical purposes; genetic testing for cancer diagnosis and treatment purposes; providing genetic sequencing and consulting services designed to provide cancer patients and oncologists with custom tailored information about the range of possible treatments and drug therapies for a particular cancer; providing information to patients and physicians to recommend cancer treatment and drug therapies based on the patient's genetic testing results; providing personalized drug therapy services for cancer patients; drug utilization review dispensing services, namely, identifying cancer drug therapies based on a patient's genetic testing results prior to dispensing medications; developing and managing comprehensive programs involving drug therapy and physician support services in the nature of providing consultation in the dispensing of prescription drugs for persons with particular cancers
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.